OTS Holdings debuts on SGX Catalist | Asian Business Review
, Singapore

OTS Holdings debuts on SGX Catalist

The company behind Golden Bridge luncheon meat launched a successful initial public offering.


Food manufacturing firm OTS Holdings is now amongst the listed companies under the Singapore Exchange (SGX) Catalist following the launch of its initial public offering.


The Company earlier reported that it estimated its net proceeds at approximately $6.56m, of which $2m will fund the expansion of their production.

This IPO listing is an important milestone for OTS Holdings, accelerating our growth strategy that involves greater regional presence and diversification through new products such as plant-based food products,” Ong Bee Chip, Managing Director, OTS Holdings Limited, said.

The company also planned to earmark some $2.5m for its overseas expansion, particularly in the Philippines; whilst around $2m more will be for developing new products and general working capital purposes.

OTS Holdings, established in 1993, produces ready-to-eat and ready-to-cook, meat products, catering to the Singapore and Malaysian market. It has a market capitalisation of $49m.

This brings the combined market capitalisation of companies under SGX Catalist to $13b. In the consumer sector alone, the market capitalisation of 137 companies stood at $76b.


Follow the links for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!


Chinese insurers deem it wise to move to alternative investments
Analysts see new regulations driving a conservative shift as insurers seek stability amidst volatile markets.
Dharmais Cancer Hospital leads cancer treatment innovation in Indonesia
CEO Soeko Werdi Nindito Daroekoesoemo unveils advanced technology and seven flagship programmes for cancer treatment.
Is ‘Londonisation’ good for Asia’s M&A insurance market?
Industry experts dissect the region’s low usage rates for M&A insurance despite more industry players entering the field.
Blurring lines between online and offline retail in Asia Pacific
Foodpanda executive explains consistent service levels through efficient logistics and quality control measures.